Filing Details
- Accession Number:
- 0001209191-17-031568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-11 17:00:33
- Reporting Period:
- 2017-05-09
- Filing Date:
- 2017-05-11
- Accepted Time:
- 2017-05-11 17:00:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1704256 | Charles Conway | C/O Biohaven Pharmaceuticals, Inc. 234 Church Street New Haven CT 06510 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2017-05-09 | 4,000 | $17.00 | 4,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects common shares purchased under the Issuer's directed share program in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
